Funding for this research was provided by:
Japan Society for the Promotion of Science (19J14908, 15H02492, 19H01015)
Japan Agency for Medical Research and Development (17bm0804003h0001, 16bm0609003h0005, 18bm0804003h0002, 19bm0804003h0003, 15bm0609003h0004)
School of Medicine, Keio University
Received: 26 December 2019
Accepted: 20 August 2020
First Online: 1 September 2020
Ethics approval and consent to participate
: Ethics approvals with human iPSCs were obtained from the Ethics Committee in Keio University School of Medicine (approval number 20080016) and the Ethics Committee on Human Tissue and Genome Research at Shionogi & Co., Ltd. (approval number KS17-027, KS18-016). Human brain samples used for experimental measures were derived from frontal cortex under approval by the institutional review board, ADCC–CNDR, and institutional ethical committee of Graduate School of Pharmaceutical Sciences, The University of Tokyo (approval number 12-1).
: Not applicable.
: The authors declare that they have no competing interests.